NCT04087057

Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer

Understanding Barriers Associated With Timely Chemotherapy Administration Among Breast Cancer Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 24 (actual)
• Sponsor: M.D. Anderson Cancer Center · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This trial studies the barriers associated with timely chemotherapy given after surgery (adjuvant) in patients with invasive breast cancer. Meeting with patients and asking questions may help doctors to learn about factors that can cause delays in the start of chemotherapy after surgery in patients with breast cancer.

Detailed description

PRIMARY OBJECTIVES: I. To comprehensively and qualitatively assess and identify the determinants of time to chemotherapy (TTC) delays in a vulnerable population using qualitative methods. Ia. To describe the health literacy/numeracy, social support and level of trust in physicians of the study participants. (Exploratory) OUTLINE: Patients complete questionnaires and participate in an interview to answer questions about the information patients received before starting the chemotherapy, any medical problems after the surgery that could have been related to the start of the chemotherapy, how the chemotherapy affected patients' life, and anything else patients may remember between the time when the breast surgery ended and the first dose of chemotherapy started. Patients' medical records are also reviewed.

Conditions

• Invasive Breast Carcinoma

Interventions

Type	Name	Description
OTHER	Interview	Participate in interview
OTHER	Medical Chart Review	Patients' medical records are reviewed
BEHAVIORAL	Questionnaire	Complete questionnaires

Timeline

• Start date: 2019-08-23
• Primary completion: 2024-04-16
• Completion: 2024-04-16
• First posted: 2019-09-12
• Last updated: 2024-04-22

Locations

1 site across 1 country: United States